GlassScriptPhysician profile
Karan Johar
NPI 1982877106
$14,303.16
in general payments reported to CMS, 2019-2025
38 companies · $1,281 in 2025
The $1,281 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,215 · 2020: $800 · 2021: $1,457 · 2022: $1,881 · 2023: $4,665 · 2024: $2,004 · 2025: $1,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,649 · Travel and Lodging: $2,286 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,649.19 |
| Travel and Lodging | $2,285.86 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,687.83 | 2019-2023 | Senza |
| Genesys Orthopedics Systems, L.L.C. | $1,434.16 | 2023 | Sacroiliac Joint Fusion System |
| Spinal Simplicity, LLC | $1,182.87 | 2023 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $1,114.24 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $776.99 | 2024 | Proclaim, Eterna |
| Globus Medical, INC. | $722.82 | 2025 | Senza, Vyrsa V1 |
| Curonix LLC | $595.54 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Axsome Therapeutics, INC. | $422.13 | 2023-2025 | Auvelity |
| Horizon Therapeutics Plc | $412.27 | 2019-2022 | |
| Merz North America, INC. | $348.60 | 2019-2021 | |
| Si-Bone, INC. | $338.05 | 2019-2025 | |
| Stimwave Technologies Incorporated | $300.57 | 2019 | |
| Nalu Medical, INC. | $263.53 | 2024-2025 | Nalu Neurostimulation System |
| Mml US, INC. | $253.21 | 2022-2023 | Reactiv8 |
| Amgen INC. | $239.00 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $213.29 | 2021 | |
| Allergan, INC. | $179.12 | 2019-2021 | |
| Galderma Laboratories, L.P. | $173.76 | 2019-2021 | |
| Vertos Medical, INC. | $167.79 | 2022 | |
| Abbvie INC. | $164.20 | 2022-2023 | |
| Spineology INC. | $144.31 | 2020 | |
| Phathom Pharmaceuticals, INC. | $143.32 | 2024 | Voquezna |
| Royal Biologics, INC. | $125.41 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.98 | 2019 | |
| Spr Therapeutics, INC | $116.16 | 2022 | |
| Melinta Therapeutics, LLC | $114.82 | 2024 | Kimyrsa |
| Medtronic USA, INC. | $113.55 | 2020 | |
| Avanos Medical | $106.09 | 2019 | |
| Collegium Pharmaceutical, INC. | $97.45 | 2020-2021 | |
| Venclose INC. | $46.33 | 2020 | |
| Medtronic, INC. | $41.95 | 2021-2025 | Accurian |
| Bioventus LLC | $29.15 | 2022 | |
| Ibsa Pharma INC. | $27.31 | 2023 | Tirosint, Licart |
| Flowonix Medical Incorporated | $24.29 | 2020 | |
| Fidia Pharma USA INC. | $15.05 | 2021 | |
| Saluda Medical Americas, INC. | $14.74 | 2024 | Evoke |
| Astrazeneca Pharmaceuticals LP | $14.50 | 2020 | |
| Epimed International, INC | $13.78 | 2025 | Catheters and Needles |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karan Johar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.